Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | ACHE | P22303 | 13/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28164347 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL28164866 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL28085686 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL18641585 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL28848111 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL723173 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL721745 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL10878591 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL28764612 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH | |
| SCHEMBL28164860 | 0.98 | EPHX1 (0.68) | EPHX1ACHENAAAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753415-B1 | NOVEL USE OF PEPTIDE COMPOUNDS FOR TREATING PAIN IN TRIGEMINAL NEURALGIA | UCB PHARMA GMBH (DE) | 2013-04-17 | — | — | EP | claimed |
| JP-4748912-B2 | — | — | 2011-08-17 | — | — | JP | claimed |
| US-7947637-B2 | Cleaning formulation for removing residues on surfaces | FUJIFILM ELECTRONIC MATERIALS, U.S.A., INC. (US) | 2011-05-24 | — | — | US | claimed |
| EP-2041776-A2 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FujiFilm Electronic Materials USA, Inc. (US) | 2009-04-01 | — | — | EP | claimed |
| WO-2008005354-A2 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080004197-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2008-01-03 | — | — | US | claimed |
| EP-1486205-B1 | Use of anticonvulsant aminoacids for the treatment of migraine | RES CORP TECHNOLOGIES INC (US) | 2007-10-17 | — | — | EP | claimed |
| EP-1486206-B1 | Uses of anticonvulsant aminoacids for the treatment of bipolar disorders | RES CORP TECHNOLOGIES INC (US) | 2007-10-17 | — | — | EP | claimed |
| US-6914122-B2 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | SCHERING CORPORATION (US) | 2005-07-05 | — | — | US | claimed |
| CN-1432022-A | Macrocyclic NS 3-serine protease inhibitors of hepatitis C virus containing alkyl and aryl alanine P2 moieties | SCHERING CORP (US) | 2003-07-23 | — | — | CN | claimed |
| EP-1274724-A2 | MACROCYCLIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS COMPRISING ALKYL AND ARYL ALANINE P2 MOIETIES | SCHERING CORPORATION (US) | 2003-01-15 | — | — | EP | claimed |
| US-20020016294-A1 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | SCHERING CORPORATION | 2002-02-07 | — | — | US | claimed |
| WO-2001081325-A2 | MACROCYCLIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS COMPRISING ALKYL AND ARYL ALANINE P2 MOIETIES | SCHERING CORPORATION (US) | 2001-11-01 | — | — | WO | claimed |
| US-4223102-A | FILMS, COATINGS, AND MOLDING MATERIALS | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-09-16 | — | — | US | claimed |
| CN-109414438-A | Composition and method for treating cancer | 塞尔利克斯生物私人有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-106232139-A | Bispecific HER2 antibody | 免疫医疗有限责任公司 | 2016-12-14 | — | — | CN | disclosed |
| CN-103857661-B | 1,2, 4-triazolyl-substituted ketoenols | 拜耳知识产权有限责任公司 | 2016-11-16 | — | — | CN | disclosed |
| EP-0010150-B1 | POLYPHOSPHAZENE POLYMERS CONTAINING SUBSTITUENT GROUPS WHICH ARE PENDENTLY BONDED TO PHOSPHORUS THROUGH NITROGEN AND PROCESS FOR THEIR PREPARATION | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1983-07-20 | — | — | EP | disclosed |
| US-4223102-A | FILMS, COATINGS, AND MOLDING MATERIALS | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-09-16 | — | — | US | disclosed |
| EP-0010150-A1 | Polyphosphazene polymers containing substituent groups which are pendently bonded to phosphorus through nitrogen and process for their preparation | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016294-A1 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | PRSS3, HPN, DPP3 | EPHX1 2002/4885ACHE 961/4885NAAA 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.